Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Chem ; 159: 178-186, 2018 Nov 05.
Article in English | MEDLINE | ID: mdl-30292895

ABSTRACT

We have previously shown the antioxidant and anti-inflammatory properties of several para-substituted arylnitroalkenes. Since oxidative stress and inflammation are key processes that drive the initiation and progression of atherosclerosis, in the present work the antioxidant, anti-inflammatory and anti-atherogenic properties of an extended library of aryl-nitroaliphatic derivatives, including several newly designed nitroalkanes, was explored. The antioxidant capacity of the nitroaliphatic compounds, measured using the oxygen radical absorbance capacity assay (ORAC) showed that the p-methylthiophenyl-derivatives were about three times more effective than Trolox to prevent fluorescein oxidation, independently of the presence or the absence of the double bond next to the nitro group. The peroxyl radical scavenger capacity of the p-dimethylaminophenyl-derivatives was even higher, being the reduced form of these compounds even more active. In fact, while the antioxidant capacity of 1-dimethylamino-4-(2-nitro-1Z-ethenyl)benzene and 1-dimethylamino-4-(2-nitro-1Z-propenyl)benzene was 4.2 ±â€¯0.1 and 5.4 ±â€¯0.1 Trolox Eq/mol, respectively; ORAC values obtained with the ethyl and the propyl derivatives were 10 ±â€¯1 and 13 ±â€¯2 Trolox Eq/mol, respectively. The p-dimethylamino-derivatives, especially the nitroalkanes, were also able to prevent LDL oxidation mediated by peroxyl radicals. Oxygen consumption due to the oxidation of fatty acids was delayed in the presence of the dimethylamino substituted compounds, only the alkanes interrupted the chain of lipid oxidations decreasing the rate of oxygen consumption. Although the formation of foam cells in the presence of oxidized-LDL (oxLDL) remained unaffected, the molecules containing the dimethylamino moiety were able to decrease the expression of IL-1ß in LPS/INF-γ challenged macrophages.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Arteriosclerosis/drug therapy , Inflammasomes/drug effects , Lipoproteins, LDL/antagonists & inhibitors , Nitro Compounds/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Lipoproteins, LDL/metabolism , Mice , Molecular Structure , Nitro Compounds/chemistry , Structure-Activity Relationship
2.
Inflamm Allergy Drug Targets ; 14(1): 19-28, 2015.
Article in English | MEDLINE | ID: mdl-26490661

ABSTRACT

In a recent work, we described the design and synthesis of arylnitroalkenes, able to scavenge macrophagederived oxidants, in particular peroxynitrite and peroxynitrite derived radicals. Four compounds emerged as potential leads, 1,1-dimethylamino-4-(2-nitro-1Z-ethenyl)benzene (1), 1,1-dimethylamino-4-(2-nitro-1Z-propenyl)benzene (2), 5- (2-nitro-1Z-ethenyl)benzo[d][1,3]dioxol (3), and 5-(2-nitro-1Z-ethenyl)benzo[d][1,3]dioxol (4). In the present work, the possibility of the preclinical validation of these molecules as anti-inflammatory and analgesic was explored in appropriate in vivo mouse models. Compounds 1, 2 and 4, administered orally as a single dose (30 µmol kg-(1)) to the mice showed anti-inflammatory and analgesic properties similar to classic nonsteroidal anti-inflammatory agents. The pharmacological effects were consistent with the inhibitory effect observed on prostaglandin endoperoxide H synthase (PGHS). In fact, both PGHS-1 and PGHS-2 were inhibited by the compounds, with compound 2 being more specific as PGHS-2 inhibitor with a specificity index superior to 70%. Conversely to classical nonsteroidal anti-inflammatory drugs, compound 2 inhibited peroxidase half reaction of the enzyme (IC50 2.3 µM) while the cyclooxygenase activity of hrPGHS-2 remained unchanged. In vitro experiments were reinforced by docking and molecular dynamics simulations showing arylnitroalkene moiety located in the region of the peroxidase active site, competing with the peroxide intermediate. The absence of toxicity and mutagenicity of the compounds was also demonstrated.


Subject(s)
Cyclooxygenase Inhibitors/pharmacology , Cycloparaffins/pharmacology , Free Radical Scavengers/pharmacology , Nitro Compounds/pharmacology , Peritonitis/drug therapy , Animals , Carrageenan/pharmacology , Cyclooxygenase Inhibitors/administration & dosage , Cyclooxygenase Inhibitors/chemistry , Cycloparaffins/administration & dosage , Cycloparaffins/chemistry , Disease Models, Animal , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/chemistry , Humans , Leukocytes/drug effects , Mice , Mice, Inbred Strains , Molecular Structure , Nitro Compounds/administration & dosage , Nitro Compounds/chemistry , Peritonitis/chemically induced , Peritonitis/immunology , Prostaglandin-Endoperoxide Synthases/metabolism
3.
Molecules ; 20(8): 14595-610, 2015 Aug 12.
Article in English | MEDLINE | ID: mdl-26274947

ABSTRACT

The current pharmacological Chagas disease treatments, using Nifurtimox or Benznidazole, show limited therapeutic results and are associated with potential side effects, like mutagenicity. Using random screening we have identified new chemotypes that were able to inhibit relevant targets of the Trypanosoma cruzi. We found 3H-[1,2]dithioles with the ability to inhibit Trypanosoma cruzi triosephosphate isomerase (TcTIM). Herein, we studied the structural modifications of this chemotype to analyze the influence of volume, lipophilicity and electronic properties in the anti-T. cruzi activity. Their selectivity to parasites vs. mammalian cells was also examined. To get insights into a possible mechanism of action, the inhibition of the enzymatic activity of TcTIM and cruzipain, using the isolated enzymes, and the inhibition of membrane sterol biosynthesis and excreted metabolites, using the whole parasite, were achieved. We found that this structural framework is interesting for the generation of innovative drugs for the treatment of Chagas disease.


Subject(s)
Toluene/analogs & derivatives , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Cell Line , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Macrophages/drug effects , Mice , Sterols/antagonists & inhibitors , Sterols/biosynthesis , Toluene/chemical synthesis , Toluene/chemistry , Toluene/pharmacology , Trypanocidal Agents/chemical synthesis , Trypanosoma cruzi/metabolism
4.
Eur J Med Chem ; 74: 31-40, 2014 Mar 03.
Article in English | MEDLINE | ID: mdl-24440380

ABSTRACT

Oxygen and nitrogen derived molecules mediated oxidation and nitration have been involved in several pathological conditions. Conversely, nitric oxide and hydrogen peroxide are important signalization intermediates, whose concentrations are tightly regulated by specialized enzyme repertoires and should remain undisturbed by the addition of exogenous antioxidant molecules, as already demonstrated by intervention studies with antioxidant vitamins. Our goal was to develop specific antioxidants able to scavenge peroxynitrite anion, as well the radicals derived from the homolytic decomposition of its conjugated acid, nitrogen dioxide and hydroxyl radical. Fourteen substituted nitroalkenes, seven 4-substituted 1-(2-nitro-1Z-ethenyl)benzene, and seven 4-substituted (2-nitro-1Z-propenyl)benzene, with different stereochemical and electronic characteristics were synthesized and tested. Compounds with the electron donor group N,N-dimethylamino showed the highest reaction rates against peroxynitrite, and also reacted with its homolytic decomposition products, OH and NO2. While 1,1-dimethylamino-4-(2-nitro-1Z-ethenyl)benzene came up as a lead for future developments without the risk of interfering with signalization pathways, since it was highly specific for peroxynitrite and peroxynitrite derived radicals, its methylated analogous 1,1-dimethylamino-4-(2-nitro-1Z-propenyl)benzene was less specific and also reacted with NO and O2(-), the biological precursor of H2O2.


Subject(s)
Alkenes/pharmacology , Macrophages/drug effects , Oxidants/metabolism , Macrophages/metabolism
5.
Biochem Mol Biol Educ ; 40(4): 266-70, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22807430

ABSTRACT

This exercise is intended to introduce undergraduate biochemistry students to the analysis of antioxidants as a biotechnological tool. In addition, some statistical resources will also be used and discussed. Antioxidants play an important metabolic role, preventing oxidative stress-mediated cell and tissue injury. Knowing the antioxidant content of nutritional components can help make informed decisions about diet design, and increase the commercial value of antioxidant-rich natural products. As a reliable and convenient technique to evaluate the whole spectrum of antioxidants present in biological samples is lacking, the general consensus is to use more than one technique. We have chosen two widely used and inexpensive methods, Trolox-equivalent antioxidant capacity and the ferric reducing antioxidant power assays, to evaluate the antioxidant content of several fruits, and to compare and analyze the correlation between both assays.


Subject(s)
Antioxidants/analysis , Biological Assay/methods , Diet , Fruit/chemistry , Humans , Oxidative Stress
6.
Bioorg Med Chem ; 20(6): 2158-71, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22356737

ABSTRACT

We report the design, the synthesis and the biological evaluation of the analgesic and anti-inflammatory activities of furoxanyl N-acylhydrazones (furoxanyl-NAH) by applying molecular hybridization approach. Hybrid compounds with IL-8-release inhibition capabilities were identified. Among them, furoxanyl-NAH, 17, and benzofuroxanyl-derivative, 24, together with furoxanyl-NAH derivative, 31, without IL-8 inhibition displayed both orally analgesic and anti-inflammatory activities. These hybrid derivatives do not have additional LOX- or COX-inhibition activities. For instance, LOX-inhibition by furoxanyl-NAH derivative, 42, emerged as a structural lead to develop new inhibitors. The lack of mutagenicity of the active derivatives 17, 31, and 42, allow us to propose them as candidates for further clinical studies. These results confirmed the success in the exploitation of hybridization strategy for identification of novel N-acylhydrazones (NAH) with optimized activities.


Subject(s)
Analgesics/chemistry , Analgesics/pharmacology , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Hydrazones/chemistry , Hydrazones/pharmacology , Analgesics/chemical synthesis , Analgesics/therapeutic use , Animals , Anti-Inflammatory Agents/chemical synthesis , Anti-Inflammatory Agents/therapeutic use , Cell Line , Cyclooxygenase Inhibitors/chemical synthesis , Cyclooxygenase Inhibitors/chemistry , Cyclooxygenase Inhibitors/pharmacology , Cyclooxygenase Inhibitors/therapeutic use , Drug Design , Female , Humans , Hydrazones/chemical synthesis , Hydrazones/therapeutic use , Inflammation/drug therapy , Interleukin-8/immunology , Lipoxygenase Inhibitors/chemical synthesis , Lipoxygenase Inhibitors/chemistry , Lipoxygenase Inhibitors/pharmacology , Lipoxygenase Inhibitors/therapeutic use , Male , Mice , Oxadiazoles/chemical synthesis , Oxadiazoles/chemistry , Oxadiazoles/pharmacology , Oxadiazoles/therapeutic use , Pain/drug therapy , Rats
7.
Bioorg Med Chem ; 18(14): 5391-9, 2010 Jul 15.
Article in English | MEDLINE | ID: mdl-20639112

ABSTRACT

Cancer preventive agents (CPA) are drugs able to suppress the carcinogen metabolic activation or block the formation of ultimate carcinogens. CPA could act through various molecular mechanisms, for example by interfering with the action of procarcinogen. This could be attained by increasing the phase II enzymes levels of quinone reductase (QR) and glutathione S-transferase (GST). New flavonoids, especially chalcones, have been identified as in vivo monofunctional phase II enzymes inducers. Oral administration of chalcone, 4, and both p-methoxy-substituted chalcones, 6 and 14, increased hepatic QR activity with concomitant decrease in CYP1A1 activity, a member of the most important group of phase I enzymes cytochrome P450. Among them, 4 also increased GST activity. While p-bromo-substituted chalcone 8 was the best inducer of QR it decreased hepatic GST expression and cytochrome P450, being the most effective decreasing cytochrome P450-expression. Thienyl-chalcone 20 being the bioisostere of chalcone 4 did not display the same in vivo profile in the phase I level modification. As chalcone 4 its bioisostere, chalcone 20, displayed low DNA strand breakage and absence of mutagenicity. Also, in our preliminary in vivo tumourigenesis/chemopreventive and acute-toxicity studies, chalcones 4, 6 and 8 showed the best behaviours as CPA justifying additional studies that are ongoing.


Subject(s)
Anticarcinogenic Agents/chemistry , Anticarcinogenic Agents/therapeutic use , Chalcones/chemistry , Chalcones/therapeutic use , Liver Neoplasms/prevention & control , Liver/drug effects , Animals , Anticarcinogenic Agents/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Chalcones/pharmacology , Comet Assay , Cytochrome P-450 CYP1A1/metabolism , Female , Humans , Liver/enzymology , Liver/pathology , Liver Neoplasms/enzymology , Models, Molecular , NAD(P)H Dehydrogenase (Quinone)/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar
8.
Arch Biochem Biophys ; 491(1-2): 96-105, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19733148

ABSTRACT

Cystathionine beta-synthase (CBS) is a homocysteine metabolizing enzyme that contains pyridoxal phosphate (PLP) and a six-coordinate heme cofactor of unknown function. CBS was inactivated by peroxynitrite, the product of nitric oxide and superoxide radicals. The IC(50) was approximately 150microM for 5microM ferric CBS. Stopped-flow kinetics and competition experiments showed a direct reaction with a second-order rate constant of (2.4-5.0)x10(4)M(-1)s(-1) (pH 7.4, 37 degrees C). The radicals derived from peroxynitrite, nitrogen dioxide and carbonate radical, also inactivated CBS. Exposure to peroxynitrite did not modify bound PLP but led to nitration of Trp208, Trp43 and Tyr223 and alterations in the heme environment including loss of thiolate coordination, conversion to high-spin and bleaching, with no detectable formation of oxo-ferryl compounds nor promotion of one-electron processes. This study demonstrates the susceptibility of CBS to reactive oxygen/nitrogen species, with potential relevance to hyperhomocysteinemia, a risk factor for cardiovascular diseases.


Subject(s)
Cystathionine beta-Synthase/metabolism , Peroxynitrous Acid/pharmacology , Carbon Dioxide/pharmacology , Chromatography, High Pressure Liquid , Cystathionine beta-Synthase/chemistry , Cystathionine beta-Synthase/genetics , Electron Spin Resonance Spectroscopy , Enzyme Activation/drug effects , Gene Deletion , Heme/analysis , Heme/metabolism , Humans , Kinetics , Mannitol/pharmacology , Mass Spectrometry , Nitric Acid/metabolism , Peroxynitrous Acid/metabolism , Phenylacetates/pharmacology , Protein Multimerization , Protein Structure, Quaternary , Spectrophotometry, Ultraviolet , Sulfhydryl Compounds/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...